 |
||
Research StaffResearch ActivitiesThe research goal of the project is to develop clinical applications for better clinical outcome of cancer patients. For this aim, we are identifing biomarkers and therapeutic targets, revealing the molecular background of cancer diversity. Cancer proteomics is carried out by collaborating with medical doctors, pathologists and industrial people. The target malignant tumors include 1) lung cancer, 2) liver cancer, 3) pancreatic cancer, 4) esophageal cancer, 5) colorectal cancer, 6) malignant soft-tissue sarcoma, 7) malignant mesothelioma, and 8) Cholangiocarcinoma. The project investigates the proteins associated with carcinogenesis and cancer development, and the proteins corresponding to histological malignancies and differentiation. The project also discovers the proteins predictive for response to chemotherapy, or metastasis/recurrence/survival after surgical operations. The novel diagnostic tools are developed using the identified proteins.Research Projects
Announcement
List of Papers Published
|
||
|
|
||
| Last Update:2010/05/24 contact |
||